Premature ovarian insufficiency: the context of long-term effects

[1]  F. Brancati,et al.  Characterization of endocrine features and genotype–phenotypes correlations in blepharophimosis–ptosis–epicanthus inversus syndrome type 1 , 2016, Journal of Endocrinological Investigation.

[2]  Jianfeng Xu,et al.  Risks associated with premature ovarian failure in Han Chinese women. , 2015, Reproductive biomedicine online.

[3]  D. Galliano,et al.  Spanish consensus on premature menopause. , 2015, Maturitas.

[4]  P. Giraldo,et al.  Vaginal epithelium and microflora characteristics in women with premature ovarian failure under hormone therapy compared to healthy women , 2015, Archives of Gynecology and Obstetrics.

[5]  C. Orlandini,et al.  Premature ovarian insufficiency: from pathogenesis to clinical management , 2015, Journal of Endocrinological Investigation.

[6]  D. Balzi,et al.  Premature ovarian insufficiency in young girls: repercussions on uterine volume and bone mineral density , 2015, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[7]  H. Critchley,et al.  Sex hormone replacement in ovarian failure - new treatment concepts. , 2015, Best practice & research. Clinical endocrinology & metabolism.

[8]  D. Portman,et al.  Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and The North American Menopause Society , 2014, Climacteric : the journal of the International Menopause Society.

[9]  G. Yeşil,et al.  Comparison of metabolic profile and abdominal fat distribution between karyotypically normal women with premature ovarian insufficiency and age matched controls. , 2014, Maturitas.

[10]  D. Portman,et al.  Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society , 2014, Menopause.

[11]  P. Giraldo,et al.  Dyspareunia and lubrication in premature ovarian failure using hormonal therapy and vaginal health , 2014, Climacteric : the journal of the International Menopause Society.

[12]  P. Bruzzi,et al.  Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials. , 2014, Cancer treatment reviews.

[13]  H. Teede,et al.  Symptoms, health behavior and understanding of menopause therapy in women with premature menopause , 2014, Climacteric : the journal of the International Menopause Society.

[14]  B. Kong,et al.  Protection of ovarian function by GnRH agonists during chemotherapy: a meta-analysis. , 2014, International journal of oncology.

[15]  X. Shu,et al.  Impact of Premature Ovarian Failure on Mortality and Morbidity among Chinese Women , 2014, PloS one.

[16]  S. Orešković,et al.  Fertility after breast cancer treatment. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[17]  D. Bennett,et al.  Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women , 2014, Neurology.

[18]  R. Bove Autoimmune diseases and reproductive aging. , 2013, Clinical immunology.

[19]  N. Naredi,et al.  Can hormone replacement therapy prior to oocyte donation cycle in women with premature ovarian failure improve pregnancy rate? , 2013, Medical journal, Armed Forces India.

[20]  A. Oto,et al.  The cardiovascular effects of premature ovarian failure. , 2013, International journal of cardiology.

[21]  M. Kulaksızoğlu,et al.  Risk Factors for Diabetes Mellitus in Women with Primary Ovarian Insufficiency , 2013, Biological Trace Element Research.

[22]  M. A. Checa,et al.  Medical alternatives to oocyte donation in women with premature ovarian failure: a systematic review , 2013, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[23]  P. Spritzer,et al.  Cardiovascular autonomic dysfunction in primary ovarian insufficiency: clinical and experimental evidence. , 2013, American journal of translational research.

[24]  Management of women with endometriosis Guideline of the European Society of Human Reproduction and Embryology , 2013 .

[25]  B. Pamuk,et al.  Serum lipid levels in women with premature ovarian failure , 2012, Menopause.

[26]  K. Oktay,et al.  Options on fertility preservation in female cancer patients. , 2012, Cancer treatment reviews.

[27]  J. Golmard,et al.  Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure. , 2011, The Journal of clinical endocrinology and metabolism.

[28]  P. Schnatz The 2010 North American Menopause Society position statement: Updates on screening, prevention and management of postmenopausal osteoporosis. , 2011, Connecticut medicine.

[29]  A. Hershlag,et al.  Part 2: Ovarian failure in adolescent cancer survivors should be treated. , 2011, Journal of pediatric and adolescent gynecology.

[30]  J. Fish Part 1: Hormone replacement for survivors of childhood cancer with ovarian failure--when is it worth the risk? , 2011, Journal of pediatric and adolescent gynecology.

[31]  C. Benetti-Pinto,et al.  Sexual function of women with premature ovarian failure , 2011, Menopause.

[32]  D. Rubinow,et al.  Depression in women with spontaneous 46, XX primary ovarian insufficiency. , 2010, The Journal of clinical endocrinology and metabolism.

[33]  L. Galluzzo,et al.  What is really responsible for bone loss in spontaneous premature ovarian failure? A new enigma , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[34]  K. Schenck-Gustafsson,et al.  EMAS position statement: Managing women with premature ovarian failure. , 2010, Maturitas.

[35]  A. Genazzani,et al.  Hypoestrogenism in young women and its influence on bone mass density , 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[36]  B. Urman,et al.  Options of Fertility Preservation in Female Cancer Patients , 2010, Obstetrical & gynecological survey.

[37]  L. Kessing,et al.  Hysterectomy, Oophorectomy and Risk of Dementia: A Nationwide Historical Cohort Study , 2010, Dementia and Geriatric Cognitive Disorders.

[38]  W. Rocca,et al.  Premature menopause or early menopause: long-term health consequences. , 2010, Maturitas.

[39]  L. Nelson Clinical practice. Primary ovarian insufficiency. , 2009, The New England journal of medicine.

[40]  B. Vollenhoven,et al.  In vitro fertilisation (IVF) with donor eggs in post-menopausal women: are there differences in pregnancy outcomes in women with premature ovarian failure (POF) compared with women with physiological age-related menopause? , 2009, Journal of Assisted Reproduction and Genetics.

[41]  J. Troendle,et al.  Bone mineral density in estrogen-deficient young women. , 2009, The Journal of clinical endocrinology and metabolism.

[42]  K. Devarajan,et al.  A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer. , 2009, Gynecologic oncology.

[43]  Demetrius M Maraganore,et al.  Long-Term Effects of Bilateral Oophorectomy on Brain Aging: Unanswered Questions from the Mayo Clinic Cohort Study of Oophorectomy and Aging , 2009, Women's health.

[44]  A. Pinto-Neto,et al.  Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure , 2009, Archives of Gynecology and Obstetrics.

[45]  M. Eijkemans,et al.  Lipid profile of women with premature ovarian failure , 2008, Menopause.

[46]  C. Lambalk,et al.  Decreased androgen concentrations and diminished general and sexual well-being in women with premature ovarian failure , 2008, Menopause.

[47]  J. Leach,et al.  Guideline Development Group , 2008 .

[48]  Sue-Kyung Park,et al.  Premenopausal factors influencing premature ovarian failure and early menopause. , 2007, Maturitas.

[49]  Elizabeth W Karlson,et al.  Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. , 2007, Arthritis and rheumatism.

[50]  R. Goswami,et al.  Prevalence of thyroid autoimmunity in sporadic idiopathic hypoparathyroidism in comparison to type 1 diabetes and premature ovarian failure. , 2006, The Journal of clinical endocrinology and metabolism.

[51]  J. Ross,et al.  Shyness, social anxiety, and impaired self-esteem in Turner syndrome and premature ovarian failure. , 2006, JAMA.

[52]  L. Dennerstein,et al.  Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. , 2006, The journal of sexual medicine.

[53]  N. Keiding,et al.  The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy. , 2006, Maturitas.

[54]  E. Calle,et al.  Age at natural menopause and cause-specific mortality. , 2005, American journal of epidemiology.

[55]  M. Merino,et al.  Autoimmune oophoritis as a mechanism of follicular dysfunction in women with 46,XX spontaneous premature ovarian failure. , 2005, Fertility and sterility.

[56]  S. Batıoğlu,et al.  Bone loss in young women with premature ovarian failure , 2005, Archives of Gynecology and Obstetrics.

[57]  L. Nelson,et al.  An update: spontaneous premature ovarian failure is not an early menopause. , 2005, Fertility and sterility.

[58]  J. Olsen,et al.  Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study , 2005, British Journal of Cancer.

[59]  G. Chrousos,et al.  Impaired endothelial function in young women with premature ovarian failure: normalization with hormone therapy. , 2004, The Journal of clinical endocrinology and metabolism.

[60]  Ivar Heuch,et al.  Age at natural menopause and all-cause mortality: a 37-year follow-up of 19,731 Norwegian women. , 2003, American journal of epidemiology.

[61]  D. V. D. Voort,et al.  Early menopause: increased fracture risk at older age , 2003, Osteoporosis International.

[62]  L. Nelson,et al.  Adrenal antibodies detect asymptomatic auto-immune adrenal insufficiency in young women with spontaneous premature ovarian failure. , 2002, Human reproduction.

[63]  E. Khedr,et al.  Effect of Surgical Menopause on Cognitive Functions , 2002, Dementia and Geriatric Cognitive Disorders.

[64]  D. Schoenfeld,et al.  Identification of premature ovarian failure patients with underlying autoimmunity. , 2000, Journal of women's health & gender-based medicine.

[65]  B. Jacobsen,et al.  Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. , 1999, Journal of clinical epidemiology.

[66]  E. Sinforiani,et al.  Memory Functioning at Menopause: Impact of Age in Ovariectomized Women , 1999, Gynecologic and Obstetric Investigation.

[67]  L. Nelson,et al.  Routine Endocrine Screening for Patients With Karyotypically Normal Spontaneous Premature Ovarian Failure , 1997, Obstetrics and gynecology.

[68]  M. Boscaro,et al.  II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. , 1997, The Journal of clinical endocrinology and metabolism.

[69]  M. Boscaro,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society I. Adrenal Cortex and Steroid 21-Hydroxylase Autoantibodies in Adult Patients with Organ-Specific Autoimmune Diseases: Markers of Low Progression , 2022 .

[70]  M. Sauer,et al.  Urodynamic Changes Following Hormonal Replacement Therapy in Women With Premature Ovarian Failure , 1989, Obstetrics and gynecology.

[71]  J. Annegers,et al.  Incidence of Premature Ovarian Failure , 1986, Obstetrics and gynecology.

[72]  F. Albright,et al.  A SYNDROME CHARACTERIZED BY PRIMARY OVARIAN INSUFFICIENCY AND DECREASED STATURE: Report of 11 Cases With a Digression on Hormonal Control of Axillary and Pubic Hair , 1942 .

[73]  F. Albright,et al.  POSTMENOPAUSAL OSTEOPOROSIS: ITS CLINICAL FEATURES , 1941 .